n the fast-paced world of biotechnology and pharmaceuticals, innovation knows no borders. Research collaborations, clinical trials, and regulatory submissions span continents, connecting teams and processes in ways that were unimaginable decades ago. But with these opportunities come new challenges—particularly in communication.

Language barriers remain a persistent obstacle in the life sciences industry, delaying clinical trial startups, complicating regulatory submissions, and increasing operational costs. These challenges are particularly significant in multinational settings, where precision and timeliness are critical to success.

Enter artificial intelligence (AI). Today, AI-powered translation tools are transforming global communication in life sciences, enabling teams to overcome traditional barriers with speed, accuracy, and scalability. These tools aren’t just closing communication gaps, they’re accelerating innovation and fostering seamless collaboration across borders.

Addressing Language Challenges with AI

For global biotech and pharma companies, translating scientific and regulatory content is a daily necessity. Research reports, regulatory submissions, and clinical trial documentation must be accurate, contextually appropriate, and accessible to diverse teams across regions. Yet, traditional translation workflows—often reliant on manual processes—are slow, expensive, and prone to error.

AI-powered translation tools offer a transformative solution. Built on advanced natural language processing (NLP) technology, these tools deliver real-time, high-accuracy translations tailored to the specific needs of life sciences. Unlike conventional methods, AI systems are equipped to handle complex scientific terminology, regulatory language, and even multilingual collaboration in dynamic, high-stakes environments.

One Company’s Journey: A Use Case in AI Transformation

A Multinational Challenge

A rapidly expanding global biotechnology company faces the daily challenge of bridging language barriers across its geographically dispersed teams. From research observations to internal communications, the need for accurate and timely translations is paramount. Any delays or inaccuracies could impede progress in a highly competitive industry.

The AI Solution

In 2024, the company piloted an AI-powered translation tool across its teams to address these challenges. The tool, built on OpenAI models, was designed to deliver fast and precise translations for key document types, including research reports, presentations, and operational communications. By integrating this solution, the company achieved a measurable reduction in turnaround times and costs while significantly improving accuracy and consistency.

The company also evaluated its AI tool’s performance for more complex document formats, such as text embedded in images and multilingual scientific presentations. The tool was tested quantitatively and qualitatively with study groups to measure efficacy and accuracy. This adaptability was crucial in meeting the diverse needs of its globally distributed workforce. The company’s current implementation of AI-powered translation tools is primarily aimed at enhancing internal communication and operational efficiency. As AI regulations and AI governance procedures evolve, the company may explore additional use cases in the future.

Results: Measurable Gains with AI Translation

The results of the company’s testing demonstrated a significant impact on operational workflows. Translation inaccuracies were reduced, as validated through internal testing using industry-standard metrics like METEOR and ROUGE scores. Turnaround times for translations shifted from weeks to minutes, and costs decreased substantially—from high outsourcing costs to a fraction of the original expense.

The charts below illustrate how AI-powered translation tools significantly reduced translation turnaround times as well as cost, enhancing operational efficiency across the company’s teams:

Figure 2: The cost per translation is reduced from thousands of dollars per document to several cents per document.

Broader Perspectives: Cactus Life Sciences and Wolfestone Group

This company’s experience reflects the broader trend of AI adoption in life sciences, with organizations like Cactus Life Sciences and Wolfestone Group leveraging these tools to address diverse challenges across the industry. While the company’s use case highlights the operational efficiency gains of AI-powered translation tools, other organizations have demonstrated their transformative potential in broader contexts.

• Cactus Life Sciences: A study by Cactus Life Sciences showed that AI-assisted translation could complete clinical document translations 200 times faster than traditional methods, reducing editing time by 67% without compromising accuracy. This approach proved especially impactful for high-volume documentation, streamlining processes critical to regulatory submissions.
• Wolfestone Group: Wolfestone Group emphasizes a hybrid approach, blending AI-driven workflows with human expertise to deliver accurate, high-quality translations tailored to medical and scientific needs. This hybrid model ensures efficiency gains while maintaining precision, particularly for patient-facing and regulatory content.

These results demonstrate how AI-powered translation tools can deliver tangible improvements across various applications, from regulatory submissions to patient-facing content.

Real-World Impact of Labeling Innovation

Another example of AI in action comes from a large multinational pharmaceutical company, where they explored AI applications to streamline their labeling process. By developing a tool capable of converting physician-level drug labels into patient-friendly versions, the company aims to reduce labor-intensive workflows and accelerate global product launches. The proposed impact? More accessible patient information and faster time to market for critical therapies.

AI tools also enhance internal operations by facilitating better communication among globally distributed teams. Whether enabling seamless collaboration across research facilities or supporting multinational product launches, these solutions are becoming indispensable in ensuring global alignment.

Benefits of AI-Driven Translation

AI-powered translation tools offer distinct benefits that resonate across the life sciences industry, from enhancing operational efficiency to improving global collaboration.

• Faster Decision-Making: By reducing translation times from weeks to minutes, AI tools enable teams to respond to challenges and opportunities more quickly. AI-powered translation tools are designed to complement human expertise, with human-in-the-loop workflows ensuring precision for complex scientific and regulatory content.
• Cost Efficiency: Automation reduces reliance on human translators, reallocating resources to strategic priorities while cutting costs.
• Consistency and Accuracy: Human-in-the-loop workflows ensure that translations remain precise and contextually relevant. AI’s ability to manage terminology databases and glossaries further strengthens consistency.
• Regulatory Readiness: AI systems help organizations meet stringent global regulatory standards by ensuring consistency and accuracy in product labels, trial documentation, and more.
• Enhanced Collaboration: Multilingual teams can work seamlessly, fostering innovation and reducing delays caused by language barriers. AI tools help align geographically dispersed teams, creating a cohesive environment for innovation.

Overcoming Implementation Challenges

Despite their transformative potential, AI-powered translation tools require careful planning to ensure successful integration. Companies must address key challenges, such as data privacy, IP protection, regulatory alignment, and tool adaptability, to maximize value while minimizing risks.

• Accuracy Assurance: Incorporate human-in-the-loop workflows to maintain precision, particularly for complex regulatory and scientific content. These workflows ensure that human oversight is maintained at critical stages, safeguarding the accuracy and contextual relevance of translations in high-stakes scenarios.
• Data Privacy: The AI tools implemented at our company are specifically designed to address internal workflows, such as research reports and operational documents, ensuring that sensitive personal data is protected. Privacy-preserving measures, including pseudonymization and anonymization, are applied to maintain compliance with global data protection regulations.
• Regulatory Alignment: AI workflows should adhere to global frameworks, such as FDA’s Good Machine Learning Practice (GMLP), to ensure transparency and traceability.
• Tool Adaptability: Evaluate AI solutions for their ability to handle various document formats, such as text embedded in images or handwritten notes, ensuring versatility across use cases.

Looking Ahead: AI’s Role in the Future of Life Sciences

The future capabilities of AI-powered translation, such as voice-to-voice translation and real-time multilingual communication, directly address critical challenges faced by the life sciences industry. These advancements promise to bridge existing gaps in global collaboration, enabling seamless communication across research teams, regulatory agencies, and clinical trial sites.

By leveraging these innovations, organizations will be better equipped to respond swiftly to regulatory changes, reduce delays in clinical trial operations, and enhance engagement with diverse patient populations. Moreover, the integration of AI with digital tools like clinical trial management systems (CTMS) and electronic trial master files (eTMF) will streamline global operations, creating an ecosystem of interconnected, efficient processes.

Conclusion: Bridging Borders, Driving Innovation

AI-powered translation tools are more than a technological advancement; they’re a catalyst for change in the global life sciences industry. By addressing communication challenges, these tools empower teams to collaborate seamlessly, accelerate timelines, and maintain compliance with diverse regulatory standards.

Case studies from the companies mentioned in this article demonstrate the transformative potential of AI. As organizations continue to explore and adopt these solutions, the vision of a truly global, connected life sciences industry is becoming a reality.

The future of biotech and pharma is one where language is no longer a barrier but a bridge to innovation and progress.